Learn More
Medchemexpress LLC 2,4-Pyrimidinediamine, N2-1H-benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)- | 1216665-49-4 | 99.9% | 332.36 | 50 MG

Supplier: Medchemexpress LLC HY1753750MG
APY29 is an ATP-competitive inhibitor and an allosteric modulator of IRE1α. It inhibits IRE1α autophosphorylation by binding to its ATP-binding pocket with an IC50 of 280 nM. Additionally, APY29 functions as a ligand that allosterically activates the adjacent RNase domain of IRE1α.
- ATP-competitive inhibitor of IRE1α
- Allosteric modulator of IRE1α
- Inhibits IRE1α autophosphorylation with an IC50 of 280 nM
- Acts as a ligand that allosterically activates the IRE1α adjacent RNase domain
- Divergently modulates the RNase activity and oligomerization state of IRE1α
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.